Highlights from the 2024 American Society of Hematology Annual Meeting - Yale's Post ASH Review

This comprehensive webinar presents Yale Cancer Center's Post ASH Review, featuring highlights from the 2024 American Society of Hematology Annual Meeting. Spanning over 6 hours, the program begins with welcome remarks by Dr. Natalia Neparidze and covers multiple specialized hematology topics. Explore updates on classical hematology including bleeding disorders, thrombosis, and sickle cell disease therapies. Delve into detailed sessions on lymphoma, covering both B-cell and T-cell Non-Hodgkin lymphoma and Hodgkin lymphoma. Learn about the latest developments in multiple myeloma treatment, including approaches for newly diagnosed patients, MGUS, smoldering myeloma, and transplant-ineligible cases. The webinar also features comprehensive sections on leukemia, including acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms, and acute lymphoblastic leukemia. A keynote presentation by Dr. Edward A. Stadtmauer focuses on immunotherapy for myeloma, covering monoclonal antibodies, T-cell engagers, and CAR T therapies. The program concludes with insights on cellular therapies and transplant approaches, presented by leading specialists in the field.